Amedisys (NASDAQ:AMED) Hits New 12-Month Low – Time to Sell?

Amedisys, Inc. (NASDAQ:AMED) reached a new 52-week low during trading on Thursday . The company traded as low as $83.73 and last traded at $83.78, with a volume of 910801 shares changing hands. The stock had previously closed at $84.97.

Amedisys Stock Performance

The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of 33.25, a P/E/G ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a 50-day simple moving average of $92.00 and a two-hundred day simple moving average of $94.75.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.98 earnings per share. On average, sell-side analysts anticipate that Amedisys, Inc. will post 4.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Amedisys

Several institutional investors have recently added to or reduced their stakes in the stock. KBC Group NV purchased a new position in Amedisys in the third quarter worth $63,000. Innealta Capital LLC acquired a new stake in shares of Amedisys in the second quarter valued at about $64,000. Signaturefd LLC lifted its stake in shares of Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after purchasing an additional 530 shares during the period. CWM LLC boosted its holdings in Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after buying an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. acquired a new position in Amedisys during the third quarter worth about $243,000. Institutional investors and hedge funds own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.